ATE275572T1 - Malto-oligosaccharid-derivate und ihre anwendungen - Google Patents

Malto-oligosaccharid-derivate und ihre anwendungen

Info

Publication number: ATE275572T1
Authority: AT; Austria
Prior art keywords: malto; applications; oligosaccharide derivatives; hyperglycemia; hydrates
Prior art date: 1999-02-22

Application number

AT00902014T

Other languages

English (en)

Inventor

Riichiro Uchida

Ayako Nasu

Yukihiko Iwai

Takao Someya

Koichiro Tobe

Original Assignee

Kikkoman Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-22

Filing date

2000-01-31

Publication date

2004-09-15

2000-01-31 Application filed by Kikkoman Corp filed Critical Kikkoman Corp

2004-09-15 Application granted granted Critical

2004-09-15 Publication of ATE275572T1 publication Critical patent/ATE275572T1/de

Links

FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 title 1
101710171801 Alpha-amylase inhibitor Proteins 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000003392 amylase inhibitor Substances 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
150000004677 hydrates Chemical class 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000001165 hydrophobic group Chemical group 0.000 abstract 1
201000001421 hyperglycemia Diseases 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Seasonings (AREA)

AT00902014T 1999-02-22 2000-01-31 Malto-oligosaccharid-derivate und ihre anwendungen ATE275572T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP04269599A JP3909735B2 (ja)	1999-02-22	1999-02-22	マルトオリゴ糖誘導体及びその用途
PCT/JP2000/000512 WO2000050434A1 (fr)	1999-02-22	2000-01-31	Derives de malto-oligosaccharide et leurs utilisations

Publications (1)

Publication Number	Publication Date
ATE275572T1 true ATE275572T1 (de)	2004-09-15

Family

ID=12643196

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00902014T ATE275572T1 (de)	1999-02-22	2000-01-31	Malto-oligosaccharid-derivate und ihre anwendungen

Country Status (7)

Country	Link
US (1)	US6596696B1 (de)
EP (1)	EP1156057B1 (de)
JP (1)	JP3909735B2 (de)
AT (1)	ATE275572T1 (de)
AU (1)	AU760621B2 (de)
DE (1)	DE60013560T2 (de)
WO (1)	WO2000050434A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19954233A1 (de) *	1999-11-11	2001-05-31	Nutricia Nv	Diabetikernahrung
WO2001094367A1 (fr) *	2000-06-06	2001-12-13	Kikkoman Corporation	Derives de malto-oligosaccharide et utilisation correspondante
FR2844453B1 (fr) *	2002-09-13	2006-05-19	Agronomique Inst Nat Rech	Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii
KR101050981B1 (ko) *	2003-01-30	2011-07-21	상꾜 가부시키가이샤	올리고당 유도체
JP2006063074A (ja) *	2004-07-29	2006-03-09	Sankyo Co Ltd	糖尿病治療薬を含有する医薬組成物
TW200612968A (en) *	2004-07-29	2006-05-01	Sankyo Co	Oligosaccharide derivatives containing with heterocycle
TW200608967A (en) *	2004-07-29	2006-03-16	Sankyo Co	Pharmaceutical compositions containing with diabetic agent
WO2009125819A1 (ja) *	2008-04-11	2009-10-15	アステラス製薬株式会社	アミノ糖化合物及びその生産方法
JP6204908B2 (ja) *	2011-05-16	2017-09-27	ヴァイタルフードプロセッサーズリミテッドＶｉｔａｌＦｏｏｄＰｒｏｃｅｓｓｏｒｓＬｉｍｉｔｅｄ	健康補助食品

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH09278789A (ja)	1996-04-16	1997-10-28	Kikkoman Corp	マルトオリゴ糖誘導体、その製造方法及び用途

1999
- 1999-02-22 JP JP04269599A patent/JP3909735B2/ja not_active Expired - Fee Related
2000
- 2000-01-31 AU AU23232/00A patent/AU760621B2/en not_active Ceased
- 2000-01-31 WO PCT/JP2000/000512 patent/WO2000050434A1/ja not_active Ceased
- 2000-01-31 EP EP00902014A patent/EP1156057B1/de not_active Expired - Lifetime
- 2000-01-31 AT AT00902014T patent/ATE275572T1/de not_active IP Right Cessation
- 2000-01-31 US US09/913,880 patent/US6596696B1/en not_active Expired - Fee Related
- 2000-01-31 DE DE60013560T patent/DE60013560T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU2323200A (en)	2000-09-14
US6596696B1 (en)	2003-07-22
AU760621B2 (en)	2003-05-22
DE60013560T2 (de)	2005-10-06
DE60013560D1 (de)	2004-10-14
WO2000050434A1 (fr)	2000-08-31
EP1156057A4 (de)	2002-07-03
EP1156057B1 (de)	2004-09-08
JP3909735B2 (ja)	2007-04-25
JP2000239293A (ja)	2000-09-05
EP1156057A1 (de)	2001-11-21

Similar Documents

Publication	Publication Date	Title
NO20020968L (no)	2002-04-26	Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
BR0212864A (pt)	2004-08-17	Derivados de 1,6-naftiridina como antidiabéticos
ATE223378T1 (de)	2002-09-15	Prolineamid-derivate
CA2336412A1 (en)	2000-01-13	Medicament for treatment of diabetes
GB0007405D0 (en)	2000-05-17	Compounds
EP1396493A4 (de)	2005-08-03	Heterocyclische verbindungen
AU7517400A (en)	2001-04-24	N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
AU8811401A (en)	2002-04-02	Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
ATE275572T1 (de)	2004-09-15	Malto-oligosaccharid-derivate und ihre anwendungen
EA200100916A1 (ru)	2002-02-28	Лекарственное средство, содержащее производное сульфопиранозилацилглицерина
EP1813270A4 (de)	2009-07-01	Proteininhibitoren der hsp90-familie
EP1374868A4 (de)	2005-03-09	Mittel zur behandlung und/oder verhütung von diabetischen ischämischen herzerkrankungen
IL161843A (en)	2011-08-31	Derivatives of 2-amino-4-pyridylmethyl-thiazoline for the preparation of medicaments for use as inhibitors of inducible no-synthase
MX9206930A (es)	1993-06-01	Nuevos compuestos
BG106520A (en)	2003-03-31	Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
BR0207966A (pt)	2004-06-15	Composição farmacêutica contendo derivados 1,3-tiazina
EP1241165A4 (de)	2003-03-19	Optisch aktive chroman- und thiochromanderivate
ATE278701T1 (de)	2004-10-15	Malto-oligosaccharide und deren verwendung
NO20060277L (no)	2006-01-19	Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
EA199900460A1 (ru)	2000-02-28	Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
EP1241167A4 (de)	2003-03-26	3-ethyl, 3-propyl- oder 3-butyl-chroman und -thiochromanderivate
EP1201664A4 (de)	2002-12-18	Bemzimidazolverbindungen und medikamente die diese enthalten
EP1151993A4 (de)	2002-04-10	Cyclische aminderivate und ihre anwendungen
DE60238847D1 (de)	2011-02-17	Pyrimidinderivate enthaltendes medikament
DK1097145T3 (da)	2003-09-15	Polyhydroxyalkylpyrazinderivater, deres fremstilling og lægemidler indeholdende disse derivater

Legal Events

Date	Code	Title	Description
2005-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties